Veeva Systems Inc. (VEEV) 주식 분석

회사 개요

Veeva Systems Inc. operates as a leading provider of cloud-based software solutions specifically designed for the life sciences industry, serving markets across North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company functions within the Healthcare sector under the Health Information Services industry, where it delivers critical infrastructure for pharmaceutical and biotechnology firms to manage commercial operations and clinical trial data. Veeva Systems Inc. currently holds a substantial market capitalization of $27.38B and generates an annual revenue of $3.20B, supported by an operational workforce of 7,928 employees. These valuation and revenue figures indicate that the enterprise is established as a significant market leader with substantial scale, commanding a premium valuation that reflects its entrenched position in the global cloud-based software ecosystem for life sciences.

재무 건전성

Veeva Systems Inc. reported a trailing twelve-month revenue of $3.20B and a net income of $908.91M, while its EBITDA stood at $984.97M, revealing a cost structure where the gap between operating earnings and net income is primarily driven by significant income tax expenses and non-operating costs. The company generated $1.05B in free cash flow, which provides a robust foundation for financial flexibility, allowing for capital allocation toward research and development or strategic acquisitions without relying on external financing. Profitability is evidenced by a gross margin of 75.5%, an operating margin of 29.4%, and a profit margin of 28.4%, indicating that the high gross margin typical of software models is effectively preserved after operating expenses and taxes. On the balance sheet, Veeva Systems Inc. holds $6.56B in cash against a relatively minor debt load of $95.86M, resulting in a conservative debt-to-equity ratio of 1.33 that suggests minimal financial leverage risk. The current ratio of 4.88 further underscores exceptional short-term liquidity, demonstrating that the company possesses ample current assets to cover its current liabilities with nearly five times the necessary margin. Additionally, the return on equity of 13.9% and return on assets of 7.3% reveal that management is effectively deploying shareholder capital and total assets to generate superior returns relative to the industry average.

밸류에이션 평가

The stock carries a trailing P/E ratio of 30.56 compared to a forward P/E of 16.85, implying that the market expects earnings growth to significantly accelerate in the coming years to justify the current high valuation multiple. The price-to-book ratio of 3.78 indicates that the market prices the company at a substantial premium over its book value, reflecting intangible assets and growth prospects not captured on the balance sheet. Alternative valuation metrics such as a price-to-sales ratio of 8.57 and an EV/EBITDA of 21.06 suggest that investors are willing to pay a high multiple for revenue and earnings power, consistent with a high-growth technology firm. The 52-week trading range spans from a low of $166.30 to a high of $310.50, providing context for price volatility and historical performance boundaries relative to the current share price. The beta value of 1.10 indicates that the stock exhibits slightly higher price volatility than the broader market, suggesting a sensitivity to market movements that is marginally amplified by the company's specific risk profile.

Growth & Income

Revenue growth is tracked at 16.0% year-over-year while earnings growth reaches 23.2% year-over-year, indicating that earnings are expanding at a faster rate than top-line revenue, which typically implies improving operational leverage or margin expansion. As a non-dividend payer, Veeva Systems Inc. maintains a dividend yield of N/A and a payout ratio of 0.0%, demonstrating a capital allocation strategy that prioritizes reinvesting earnings into business growth rather than distributing cash to shareholders. This approach to capital deployment is consistent with the company's growth stage, where retaining cash for innovation and market expansion is often more valuable than providing dividend income. The overall growth and income profile is characterized by double-digit revenue expansion and accelerating earnings growth, supported by a complete retention of earnings to fuel future strategic initiatives.